Thiabendazole adverse reactions: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) mNo edit summary |
Gerald Chi (talk | contribs) |
||
| Line 7: | Line 7: | ||
* '''Gastrointestinal''': [[anorexia]], [[nausea]], [[vomiting]], [[diarrhea]], epigastric distress, [[abdominal pain]], [[jaundice]], [[cholestasis]], parenchymal liver damage and [[hepatic failure]]. (See WARNINGS.) | * '''Gastrointestinal''': [[anorexia]], [[nausea]], [[vomiting]], [[diarrhea]], epigastric distress, [[abdominal pain]], [[jaundice]], [[cholestasis]], parenchymal liver damage and [[hepatic failure]]. (See WARNINGS.) | ||
* '''Central Nervous System''': [[dizziness]], weariness, [[drowsiness]], giddiness, [[headache]], [[numbness]], hyperirritability, [[convulsion]]s, collapse, [[confusion]], [[depression]], floating sensation, [[ | * '''Central Nervous System''': [[dizziness]], weariness, [[drowsiness]], giddiness, [[headache]], [[numbness]], hyperirritability, [[convulsion]]s, collapse, [[confusion]], [[depression]], floating sensation, [[weakness]] and lack of coordination. | ||
* '''Special Senses''': [[tinnitus]], abnormal sensation in eyes, xanthopsia, blurred vision, reduced vision, drying of mucous membranes (mouth, eyes, etc.), Sicca syndrome. (See WARNINGS.) | * '''Special Senses''': [[tinnitus]], abnormal sensation in eyes, xanthopsia, blurred vision, reduced vision, drying of mucous membranes (mouth, eyes, etc.), Sicca syndrome. (See WARNINGS.) | ||
Revision as of 23:05, 6 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Adverse Reactions
- Gastrointestinal: anorexia, nausea, vomiting, diarrhea, epigastric distress, abdominal pain, jaundice, cholestasis, parenchymal liver damage and hepatic failure. (See WARNINGS.)
- Central Nervous System: dizziness, weariness, drowsiness, giddiness, headache, numbness, hyperirritability, convulsions, collapse, confusion, depression, floating sensation, weakness and lack of coordination.
- Special Senses: tinnitus, abnormal sensation in eyes, xanthopsia, blurred vision, reduced vision, drying of mucous membranes (mouth, eyes, etc.), Sicca syndrome. (See WARNINGS.)
- Cardiovascular: hypotension.
- Metabolic: hyperglycemia.
- Hematologic: transient leukopenia.
- Genitourinary: hematuria, enuresis, malodor of the urine, crystalluria.
- Hypersensitivity: pruritus, fever, facial flush, chills, conjunctival injection, angioedema, anaphylaxis, skin rashes (including perianal), erythema multiforme (including Stevens-Johnson syndrome), and lymphadenopathy.
- Miscellaneous: appearance of live Ascaris in the mouth and nose.[1]
References
- ↑ "http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/16096slr033,16097slr026_mintezol_lbl.pdf" (PDF). External link in
|title=(help)
Adapted from the FDA Package Insert.